Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol
We have recently shown that a contact force (CF)-guided ablation protocol respecting region-specific criteria of lesion contiguity and lesion depth ('CLOSE' protocol) is associated with high incidence of acute durable pulmonary vein (PV) isolation (PVI) and a high single-procedure arrhythm...
        Saved in:
      
    
          | Published in | Europace (London, England) Vol. 20; no. FI_3; pp. f419 - f427 | 
|---|---|
| Main Authors | , , , , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        England
        
        01.11.2018
     | 
| Online Access | Get full text | 
| ISSN | 1099-5129 1532-2092 1532-2092  | 
| DOI | 10.1093/europace/eux376 | 
Cover
| Abstract | We have recently shown that a contact force (CF)-guided ablation protocol respecting region-specific criteria of lesion contiguity and lesion depth ('CLOSE' protocol) is associated with high incidence of acute durable pulmonary vein (PV) isolation (PVI) and a high single-procedure arrhythmia-free survival at 1 year. In the present study, we compared efficiency, safety, and efficacy of 'CLOSE'-guided PVI to conventional CF-guided PVI (CONV-CF).
Fifty consecutive paroxysmal atrial fibrillation (AF) patients underwent PV encircling using a CF-sensing catheter targeting an interlesion distance (ILD) ≤6 mm and ablation index (AI) ≥400 and ≥550 at posterior and anterior wall ('CLOSE' group). Results were compared to the last 50 patients undergoing 'CONV-CF'. All patients underwent adenosine testing after PVI. Arrhythmia recurrence was defined as any atrial tachyarrhythmia (ATA) >30 s on Holter at 3, 6, and 12 months. Clinical characteristics did not differ. Contact force variability was comparable in between both groups (proportion of applications with intermittent contact 2% in 'CLOSE' vs. 1% in CONV-CF, P = 0.67). In the 'CLOSE' group, procedure time and radiofrequency (RF) time per circle were shorter (respectively 149 ± 33 min vs. 192 ± 42 min, P < 0.0001 and 18 ± 4 min vs 28 ± 7.5 min, P < 0.0001) and incidence of adenosine-proof isolation was higher (97% vs. 82%, P < 0.001). No complications were observed in the 'CLOSE' group, one tamponade in the 'CONV-CF' group. At 12 months, single-procedure freedom from ATA was 94% in 'CLOSE' vs. 80% in 'CONV-CF' group (P < 0.05). In both groups, the majority of reconnections at repeat were associated with either ILD > 6 mm and/or AI < 400/550 (100% vs. 83%, P = 0.99).
'CLOSE'-guided PVI improves procedural and 1 year outcome in CF-guided PVI while shortening procedure time. Improvement cannot be explained by differences in CF variability and is most likely due to the strict application of criteria for contiguity and ablation index. A randomized controlled trial is needed to exclude the possible contribution of a learning curve. | 
    
|---|---|
| AbstractList | We have recently shown that a contact force (CF)-guided ablation protocol respecting region-specific criteria of lesion contiguity and lesion depth ('CLOSE' protocol) is associated with high incidence of acute durable pulmonary vein (PV) isolation (PVI) and a high single-procedure arrhythmia-free survival at 1 year. In the present study, we compared efficiency, safety, and efficacy of 'CLOSE'-guided PVI to conventional CF-guided PVI (CONV-CF).
Fifty consecutive paroxysmal atrial fibrillation (AF) patients underwent PV encircling using a CF-sensing catheter targeting an interlesion distance (ILD) ≤6 mm and ablation index (AI) ≥400 and ≥550 at posterior and anterior wall ('CLOSE' group). Results were compared to the last 50 patients undergoing 'CONV-CF'. All patients underwent adenosine testing after PVI. Arrhythmia recurrence was defined as any atrial tachyarrhythmia (ATA) >30 s on Holter at 3, 6, and 12 months. Clinical characteristics did not differ. Contact force variability was comparable in between both groups (proportion of applications with intermittent contact 2% in 'CLOSE' vs. 1% in CONV-CF, P = 0.67). In the 'CLOSE' group, procedure time and radiofrequency (RF) time per circle were shorter (respectively 149 ± 33 min vs. 192 ± 42 min, P < 0.0001 and 18 ± 4 min vs 28 ± 7.5 min, P < 0.0001) and incidence of adenosine-proof isolation was higher (97% vs. 82%, P < 0.001). No complications were observed in the 'CLOSE' group, one tamponade in the 'CONV-CF' group. At 12 months, single-procedure freedom from ATA was 94% in 'CLOSE' vs. 80% in 'CONV-CF' group (P < 0.05). In both groups, the majority of reconnections at repeat were associated with either ILD > 6 mm and/or AI < 400/550 (100% vs. 83%, P = 0.99).
'CLOSE'-guided PVI improves procedural and 1 year outcome in CF-guided PVI while shortening procedure time. Improvement cannot be explained by differences in CF variability and is most likely due to the strict application of criteria for contiguity and ablation index. A randomized controlled trial is needed to exclude the possible contribution of a learning curve. We have recently shown that a contact force (CF)-guided ablation protocol respecting region-specific criteria of lesion contiguity and lesion depth ('CLOSE' protocol) is associated with high incidence of acute durable pulmonary vein (PV) isolation (PVI) and a high single-procedure arrhythmia-free survival at 1 year. In the present study, we compared efficiency, safety, and efficacy of 'CLOSE'-guided PVI to conventional CF-guided PVI (CONV-CF).AimsWe have recently shown that a contact force (CF)-guided ablation protocol respecting region-specific criteria of lesion contiguity and lesion depth ('CLOSE' protocol) is associated with high incidence of acute durable pulmonary vein (PV) isolation (PVI) and a high single-procedure arrhythmia-free survival at 1 year. In the present study, we compared efficiency, safety, and efficacy of 'CLOSE'-guided PVI to conventional CF-guided PVI (CONV-CF).Fifty consecutive paroxysmal atrial fibrillation (AF) patients underwent PV encircling using a CF-sensing catheter targeting an interlesion distance (ILD) ≤6 mm and ablation index (AI) ≥400 and ≥550 at posterior and anterior wall ('CLOSE' group). Results were compared to the last 50 patients undergoing 'CONV-CF'. All patients underwent adenosine testing after PVI. Arrhythmia recurrence was defined as any atrial tachyarrhythmia (ATA) >30 s on Holter at 3, 6, and 12 months. Clinical characteristics did not differ. Contact force variability was comparable in between both groups (proportion of applications with intermittent contact 2% in 'CLOSE' vs. 1% in CONV-CF, P = 0.67). In the 'CLOSE' group, procedure time and radiofrequency (RF) time per circle were shorter (respectively 149 ± 33 min vs. 192 ± 42 min, P < 0.0001 and 18 ± 4 min vs 28 ± 7.5 min, P < 0.0001) and incidence of adenosine-proof isolation was higher (97% vs. 82%, P < 0.001). No complications were observed in the 'CLOSE' group, one tamponade in the 'CONV-CF' group. At 12 months, single-procedure freedom from ATA was 94% in 'CLOSE' vs. 80% in 'CONV-CF' group (P < 0.05). In both groups, the majority of reconnections at repeat were associated with either ILD > 6 mm and/or AI < 400/550 (100% vs. 83%, P = 0.99).Methods and resultsFifty consecutive paroxysmal atrial fibrillation (AF) patients underwent PV encircling using a CF-sensing catheter targeting an interlesion distance (ILD) ≤6 mm and ablation index (AI) ≥400 and ≥550 at posterior and anterior wall ('CLOSE' group). Results were compared to the last 50 patients undergoing 'CONV-CF'. All patients underwent adenosine testing after PVI. Arrhythmia recurrence was defined as any atrial tachyarrhythmia (ATA) >30 s on Holter at 3, 6, and 12 months. Clinical characteristics did not differ. Contact force variability was comparable in between both groups (proportion of applications with intermittent contact 2% in 'CLOSE' vs. 1% in CONV-CF, P = 0.67). In the 'CLOSE' group, procedure time and radiofrequency (RF) time per circle were shorter (respectively 149 ± 33 min vs. 192 ± 42 min, P < 0.0001 and 18 ± 4 min vs 28 ± 7.5 min, P < 0.0001) and incidence of adenosine-proof isolation was higher (97% vs. 82%, P < 0.001). No complications were observed in the 'CLOSE' group, one tamponade in the 'CONV-CF' group. At 12 months, single-procedure freedom from ATA was 94% in 'CLOSE' vs. 80% in 'CONV-CF' group (P < 0.05). In both groups, the majority of reconnections at repeat were associated with either ILD > 6 mm and/or AI < 400/550 (100% vs. 83%, P = 0.99).'CLOSE'-guided PVI improves procedural and 1 year outcome in CF-guided PVI while shortening procedure time. Improvement cannot be explained by differences in CF variability and is most likely due to the strict application of criteria for contiguity and ablation index. A randomized controlled trial is needed to exclude the possible contribution of a learning curve.Conclusion'CLOSE'-guided PVI improves procedural and 1 year outcome in CF-guided PVI while shortening procedure time. Improvement cannot be explained by differences in CF variability and is most likely due to the strict application of criteria for contiguity and ablation index. A randomized controlled trial is needed to exclude the possible contribution of a learning curve.  | 
    
| Author | Vandekerckhove, Yves El Haddad, Milad Wolf, Michael Phlips, Thomas Tavernier, René Knecht, Sébastien Duytschaever, Mattias Taghji, Philippe  | 
    
| Author_xml | – sequence: 1 givenname: Thomas surname: Phlips fullname: Phlips, Thomas organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium – sequence: 2 givenname: Philippe surname: Taghji fullname: Taghji, Philippe organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium – sequence: 3 givenname: Milad surname: El Haddad fullname: El Haddad, Milad organization: Department of Internal Medicine, Ghent University, De Pintelaan 185, Ghent, Belgium – sequence: 4 givenname: Michael surname: Wolf fullname: Wolf, Michael organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium – sequence: 5 givenname: Sébastien surname: Knecht fullname: Knecht, Sébastien organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium – sequence: 6 givenname: Yves surname: Vandekerckhove fullname: Vandekerckhove, Yves organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium – sequence: 7 givenname: René surname: Tavernier fullname: Tavernier, René organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium – sequence: 8 givenname: Mattias surname: Duytschaever fullname: Duytschaever, Mattias organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium, Department of Internal Medicine, Ghent University, De Pintelaan 185, Ghent, Belgium  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29315411$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNqFUctuFDEQtFBQ3mduyEcOGeLHeDbmhlYhRFopB8h55PG0g5HHHmzPJnvLZ8Av8Rn5kpidBAkOcOq2urqq2nWAdnzwgNArSt5SIvkpTDGMSkNp7viieYH2qeCsYkSyndITKStBmdxDByl9JYQsmBS7aI9JTkVN6T76eTmMMaytv8GlauinqBxWvsdFqNqAijhMWYcBsDIZItbBZ6UzNiFqqG4m20OPx8kNwau4wWuwHtsUnMo2-Hc4fwEcgwMcDLa-EDhIZYB7m7LyGk6w6mZsGfdwd7LV_kMEr1W0qrPO5k0BbSkf7r8vV1efzh_uf1TFdw46uCP00iiX4PipHqLrD-eflx-r1dXF5fL9qtI1qXMlNKmJVKavGyBEi9pwzRadrjkx5c0Jr89MZ5hhmhoAIgTv6YJ0vOloIxvCDxGZeSc_qs2tcq4dox3K9S0l7a9Y2udY2jmWsvJmXilev02QcjvYpME55SFMqaXyTApRMykL9PUTdOoG6H9TP0dWAGIG6BhSimBabfP2B3NU1v3Dw-lfe_9z_QhUesbZ | 
    
| CitedBy_id | crossref_primary_10_1111_jce_15433 crossref_primary_10_1111_jce_15674 crossref_primary_10_1002_joa3_13035 crossref_primary_10_1007_s10840_022_01229_6 crossref_primary_10_1007_s10840_024_01810_1 crossref_primary_10_3389_fcvm_2022_1073239 crossref_primary_10_1007_s10840_019_00691_z crossref_primary_10_35336_VA_1327 crossref_primary_10_1111_prd_12561 crossref_primary_10_1007_s10840_020_00751_9 crossref_primary_10_1093_europace_euad259 crossref_primary_10_1093_europace_euae103 crossref_primary_10_1002_joa3_12868 crossref_primary_10_1016_j_hlc_2021_02_017 crossref_primary_10_1136_openhrt_2024_002873 crossref_primary_10_1148_radiol_212644 crossref_primary_10_3390_ijerph20075250 crossref_primary_10_1111_jce_13928 crossref_primary_10_1007_s10554_022_02533_y crossref_primary_10_2169_internalmedicine_9367_22 crossref_primary_10_1016_j_pcad_2021_06_005 crossref_primary_10_1016_j_rccl_2019_01_001 crossref_primary_10_1001_jamacardio_2023_0212 crossref_primary_10_1016_j_jacep_2023_05_015 crossref_primary_10_3389_fcvm_2024_1449623 crossref_primary_10_1155_2021_8821467 crossref_primary_10_1007_s10840_019_00687_9 crossref_primary_10_1111_jce_16194 crossref_primary_10_1007_s00392_021_01973_1 crossref_primary_10_1002_joa3_12611 crossref_primary_10_1111_pace_14578 crossref_primary_10_1111_jce_14124 crossref_primary_10_1111_jce_15575 crossref_primary_10_1111_pace_14228 crossref_primary_10_1016_j_hrthm_2019_01_030 crossref_primary_10_1111_jce_16542 crossref_primary_10_3390_jcm12154982 crossref_primary_10_35336_VA_2021_E_3_16 crossref_primary_10_1007_s10840_018_0501_5 crossref_primary_10_1016_j_ijcha_2020_100574 crossref_primary_10_3389_fcvm_2023_1141698 crossref_primary_10_1136_openhrt_2021_001718 crossref_primary_10_3389_fcvm_2022_937913 crossref_primary_10_1007_s11936_024_01043_5 crossref_primary_10_3904_kjm_2022_97_1_5 crossref_primary_10_35336_VA_1310 crossref_primary_10_1111_jce_14598 crossref_primary_10_3390_biomedicines11123261 crossref_primary_10_1016_j_recesp_2020_10_022 crossref_primary_10_1253_circj_CJ_24_0476 crossref_primary_10_47803_rjc_2020_30_4_553 crossref_primary_10_1016_j_ejim_2023_02_011 crossref_primary_10_1093_europace_euad244 crossref_primary_10_1016_j_jacep_2019_12_006 crossref_primary_10_1016_j_banm_2024_04_004 crossref_primary_10_1016_j_jacep_2018_11_020 crossref_primary_10_1093_europace_euaa418 crossref_primary_10_3389_fcvm_2023_1223064 crossref_primary_10_1016_j_ijcard_2022_10_013 crossref_primary_10_1111_jce_15356 crossref_primary_10_1016_j_jacep_2022_06_007 crossref_primary_10_1111_jce_13730 crossref_primary_10_36660_abc_20240355i crossref_primary_10_1007_s10840_024_01771_5 crossref_primary_10_3389_fcvm_2022_949918 crossref_primary_10_1002_joa3_13192 crossref_primary_10_1111_jce_14706 crossref_primary_10_1111_jce_16208 crossref_primary_10_1136_bmjopen_2018_023775 crossref_primary_10_1093_europace_euab279 crossref_primary_10_3390_jcm10184268 crossref_primary_10_1002_joa3_12544 crossref_primary_10_1007_s10840_023_01690_x crossref_primary_10_1111_jce_14381 crossref_primary_10_1111_pace_13673 crossref_primary_10_3389_fcvm_2021_782451 crossref_primary_10_1002_joa3_12424 crossref_primary_10_1111_pace_14656 crossref_primary_10_1016_j_jacep_2023_08_005 crossref_primary_10_1016_j_jacep_2020_08_023 crossref_primary_10_3389_fcvm_2023_1073108 crossref_primary_10_1111_jce_14495 crossref_primary_10_1159_000508888 crossref_primary_10_3389_fcvm_2025_1552340 crossref_primary_10_35336_VA_2020_1_55_62 crossref_primary_10_1093_europace_euad221 crossref_primary_10_1111_jce_15106 crossref_primary_10_1016_j_repc_2021_05_019 crossref_primary_10_3390_diseases12020038 crossref_primary_10_1007_s10840_020_00881_0 crossref_primary_10_1007_s10840_025_01982_4 crossref_primary_10_1007_s10840_022_01434_3 crossref_primary_10_35336_VA_1186 crossref_primary_10_1016_j_hrthm_2024_03_017 crossref_primary_10_1111_pace_14309 crossref_primary_10_3389_fcvm_2021_817299 crossref_primary_10_1007_s10840_020_00927_3 crossref_primary_10_1093_europace_euad310 crossref_primary_10_5604_01_3001_0014_1503 crossref_primary_10_1093_europace_euae088 crossref_primary_10_1093_europace_euac103 crossref_primary_10_1007_s10840_019_00565_4 crossref_primary_10_1111_jce_15809 crossref_primary_10_1007_s00399_022_00843_1 crossref_primary_10_1007_s00399_022_00889_1 crossref_primary_10_1007_s10840_023_01709_3 crossref_primary_10_1111_jce_14156 crossref_primary_10_1111_pace_14315 crossref_primary_10_1253_circj_CJ_19_0993 crossref_primary_10_1016_j_jacep_2023_05_034 crossref_primary_10_1111_jce_15000 crossref_primary_10_1111_jce_16573 crossref_primary_10_2459_JCM_0000000000000779 crossref_primary_10_1016_j_jacep_2020_09_027 crossref_primary_10_1111_jce_13625 crossref_primary_10_1002_joa3_13082 crossref_primary_10_1093_europace_euab261 crossref_primary_10_1093_europace_euab268 crossref_primary_10_1093_europace_euac236 crossref_primary_10_31083_j_rcm2504140 crossref_primary_10_1111_jce_14709 crossref_primary_10_1016_j_jacep_2024_02_026 crossref_primary_10_1161_CIRCEP_120_009112 crossref_primary_10_1111_pace_14555 crossref_primary_10_1186_s42444_020_00021_9 crossref_primary_10_1007_s10840_023_01663_0 crossref_primary_10_1111_jce_16006 crossref_primary_10_3389_fcvm_2022_922910 crossref_primary_10_1111_jce_14980 crossref_primary_10_33590_emjcardiol_10310415 crossref_primary_10_3389_fcvm_2022_941434 crossref_primary_10_36660_abc_20240355 crossref_primary_10_1111_jce_15717 crossref_primary_10_1093_europace_euaa383 crossref_primary_10_1111_jvim_17251 crossref_primary_10_1093_europace_euae067 crossref_primary_10_1253_circj_CJ_18_0361 crossref_primary_10_1093_europace_euab114 crossref_primary_10_1093_europace_euaa147 crossref_primary_10_1093_europace_euab115 crossref_primary_10_36660_abc_20230544 crossref_primary_10_1111_jce_15152 crossref_primary_10_1016_j_jacep_2019_09_004 crossref_primary_10_1016_j_jacep_2024_09_021 crossref_primary_10_1016_j_ahj_2022_02_009 crossref_primary_10_1111_jce_15028 crossref_primary_10_1093_europace_euae072 crossref_primary_10_1007_s00392_019_01428_8 crossref_primary_10_1016_j_jacep_2022_10_039 crossref_primary_10_1093_europace_euz226 crossref_primary_10_1016_j_jacep_2020_06_030 crossref_primary_10_1093_europace_euae194 crossref_primary_10_2217_cer_2019_0165 crossref_primary_10_1111_jce_15703 crossref_primary_10_1007_s10840_022_01131_1 crossref_primary_10_1038_s41598_020_61322_6 crossref_primary_10_36660_abc_20200204 crossref_primary_10_1007_s10840_021_01053_4 crossref_primary_10_1007_s00399_021_00794_z crossref_primary_10_1093_ehjopen_oeae014 crossref_primary_10_1002_joa3_12696 crossref_primary_10_1007_s00380_021_01971_3 crossref_primary_10_1111_jce_16230 crossref_primary_10_1016_j_ipej_2021_08_005 crossref_primary_10_1111_jce_16026 crossref_primary_10_1111_jce_15610 crossref_primary_10_1111_jce_15731 crossref_primary_10_1007_s10840_021_00990_4 crossref_primary_10_1093_europace_euae043 crossref_primary_10_1111_jce_15855 crossref_primary_10_3390_jcdd10030098 crossref_primary_10_1093_europace_euz115 crossref_primary_10_3389_fcvm_2022_986207 crossref_primary_10_1016_j_hlc_2021_04_007 crossref_primary_10_1016_j_hrcr_2021_09_012 crossref_primary_10_1016_j_hroo_2024_11_025 crossref_primary_10_1111_jce_15294 crossref_primary_10_35336_VA_2020_3_9_24 crossref_primary_10_1093_eurheartj_ehaa612 crossref_primary_10_1161_CIRCOUTCOMES_124_010877 crossref_primary_10_1016_j_hrthm_2019_11_004 crossref_primary_10_1111_jce_15608 crossref_primary_10_1093_europace_euz244 crossref_primary_10_1007_s10554_019_01727_1 crossref_primary_10_1007_s10840_020_00880_1 crossref_primary_10_1111_jce_14193 crossref_primary_10_1002_joa3_12597 crossref_primary_10_1016_j_hrcr_2023_03_016 crossref_primary_10_1111_jce_15041 crossref_primary_10_1111_pace_14751 crossref_primary_10_1007_s00399_018_0586_7 crossref_primary_10_35336_VA_1362 crossref_primary_10_1016_j_hrthm_2024_07_094 crossref_primary_10_2169_naika_107_1744 crossref_primary_10_1093_ehjcr_ytaf101 crossref_primary_10_1093_europace_euad053 crossref_primary_10_1093_europace_euae260 crossref_primary_10_1055_a_1464_0612 crossref_primary_10_3390_jcm12247556 crossref_primary_10_1016_j_ccep_2020_03_001 crossref_primary_10_1093_europace_euaa224 crossref_primary_10_3389_fcvm_2024_1474002 crossref_primary_10_1080_17434440_2020_1768846 crossref_primary_10_1111_pace_14124 crossref_primary_10_1111_pace_14125 crossref_primary_10_1161_CIRCEP_119_007247 crossref_primary_10_1111_pace_14931 crossref_primary_10_1002_joa3_70016 crossref_primary_10_1016_j_jacep_2023_03_020 crossref_primary_10_1007_s12265_020_10037_0 crossref_primary_10_1111_jce_15748 crossref_primary_10_3389_fcvm_2023_1278635 crossref_primary_10_1136_heartjnl_2020_318676 crossref_primary_10_36660_abc_20230544i crossref_primary_10_1111_jce_15504 crossref_primary_10_1161_CIRCEP_120_009294 crossref_primary_10_1093_europace_euaa354 crossref_primary_10_1080_00015385_2021_1939512 crossref_primary_10_1016_j_hjc_2023_03_001 crossref_primary_10_1111_evj_14037 crossref_primary_10_1093_europace_euab329 crossref_primary_10_1111_jce_16393 crossref_primary_10_1016_j_jacep_2023_06_004 crossref_primary_10_1186_s42444_022_00064_0 crossref_primary_10_1371_journal_pone_0257050 crossref_primary_10_1007_s12325_019_01173_4 crossref_primary_10_1016_j_jacep_2019_05_007 crossref_primary_10_1016_j_hrthm_2020_03_016 crossref_primary_10_1536_ihj_22_091 crossref_primary_10_3390_jcm11030830 crossref_primary_10_1016_j_jacep_2018_08_016 crossref_primary_10_1007_s10840_019_00622_y crossref_primary_10_1002_joa3_12605 crossref_primary_10_1111_pace_14140 crossref_primary_10_1007_s10840_021_00944_w crossref_primary_10_1002_joa3_12960 crossref_primary_10_2217_fca_2021_0002 crossref_primary_10_1002_joa3_12601 crossref_primary_10_1155_2022_6009275 crossref_primary_10_3238_PersKardio_2020_04_10_03 crossref_primary_10_1111_jce_14673 crossref_primary_10_1111_jce_14311 crossref_primary_10_1111_jce_15883 crossref_primary_10_35336_VA_1356 crossref_primary_10_1111_jce_14678 crossref_primary_10_1111_jce_14438 crossref_primary_10_3389_fcvm_2023_1276317 crossref_primary_10_3389_fcvm_2023_1332868 crossref_primary_10_1038_s41569_019_0261_7 crossref_primary_10_17925_EJAE_2022_8_1_2 crossref_primary_10_3390_jcdd11040110 crossref_primary_10_3389_fphys_2020_00987 crossref_primary_10_1016_j_hrthm_2020_03_022  | 
    
| Cites_doi | 10.1001/jama.2009.2029 10.1093/europace/euv206 10.1016/j.jacc.2014.04.072 10.1093/europace/eus027 10.1111/j.1540-8167.2009.01646.x 10.1093/europace/euw295 10.1111/j.1540-8167.2010.01750.x 10.1056/NEJMoa1602014 10.1111/jce.12303 10.1161/01.CIR.102.1.67 10.1016/j.hrthm.2014.07.033 10.1016/j.hrthm.2016.05.011 10.1161/CIRCEP.115.003041 10.1161/CIRCEP.116.004867 10.1016/j.hrthm.2017.04.024 10.1016/j.hrthm.2015.06.026 10.1161/CIRCULATIONAHA.114.014092  | 
    
| ContentType | Journal Article | 
    
| DBID | AAYXX CITATION NPM 7X8 ADTOC UNPAY  | 
    
| DOI | 10.1093/europace/eux376 | 
    
| DatabaseName | CrossRef PubMed MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall  | 
    
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic  | 
    
| DatabaseTitleList | PubMed MEDLINE - Academic  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Medicine | 
    
| EISSN | 1532-2092 | 
    
| EndPage | f427 | 
    
| ExternalDocumentID | 10.1093/europace/eux376 29315411 10_1093_europace_eux376  | 
    
| Genre | Journal Article | 
    
| GroupedDBID | --- .2P .I3 .XZ .ZR 0R~ 29G 2WC 4.4 48X 53G 5GY 5VS 5WA 6PF 70D AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPNW AAPQZ AAPXW AAUAY AAUQX AAVAP AAWTL AAYXX ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNHQ ABNKS ABPQP ABPTD ABQLI ABVGC ABWST ABXVV ABZBJ ACGFS ACPRK ACUFI ACUTO ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADOCK ADRTK ADVEK ADYVW ADZXQ AEGPL AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHXPO AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX AMNDL APIBT APWMN AXUDD BAWUL BAYMD BEYMZ BHONS BTRTY BVRKM CDBKE CITATION CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IOX J21 JXSIZ KBUDW KOP KQ8 KSI KSN M-Z MHKGH N9A NGC NOMLY NOYVH O9- OAUYM OAWHX ODMLO OJQWA OJZSN OK1 OPAEJ OVD P2P PAFKI PEELM PQQKQ Q1. Q5Y RD5 ROL RPM RUSNO RW1 RXO SEL SV3 TCURE TEORI TJX TOX TR2 VVN W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 NPM 7X8 --K 1B1 1TH ADTOC C1A CAG COF IHE M41 NQ- NTWIH NU- O0~ RPZ UHS UNPAY  | 
    
| ID | FETCH-LOGICAL-c404t-5c0409afd46e00c54f3c27bc430f00c30348fbf2f2c1fee0553d170b36b169603 | 
    
| IEDL.DBID | UNPAY | 
    
| ISSN | 1099-5129 1532-2092  | 
    
| IngestDate | Tue Aug 19 22:04:14 EDT 2025 Thu Oct 02 11:45:33 EDT 2025 Mon Jul 21 05:53:08 EDT 2025 Thu Apr 24 23:01:05 EDT 2025 Tue Jul 01 03:20:18 EDT 2025  | 
    
| IsDoiOpenAccess | true | 
    
| IsOpenAccess | true | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | FI_3 | 
    
| Language | English | 
    
| License | https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c404t-5c0409afd46e00c54f3c27bc430f00c30348fbf2f2c1fee0553d170b36b169603 | 
    
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23  | 
    
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://academic.oup.com/europace/article-pdf/20/FI_3/f419/26947528/eux376.pdf | 
    
| PMID | 29315411 | 
    
| PQID | 1989554299 | 
    
| PQPubID | 23479 | 
    
| ParticipantIDs | unpaywall_primary_10_1093_europace_eux376 proquest_miscellaneous_1989554299 pubmed_primary_29315411 crossref_citationtrail_10_1093_europace_eux376 crossref_primary_10_1093_europace_eux376  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | 2018-11-01 | 
    
| PublicationDateYYYYMMDD | 2018-11-01 | 
    
| PublicationDate_xml | – month: 11 year: 2018 text: 2018-11-01 day: 01  | 
    
| PublicationDecade | 2010 | 
    
| PublicationPlace | England | 
    
| PublicationPlace_xml | – name: England | 
    
| PublicationTitle | Europace (London, England) | 
    
| PublicationTitleAlternate | Europace | 
    
| PublicationYear | 2018 | 
    
| References | Shah ( key 2018120305264948300_eux376-B5) 2010; 21 Taghji ( key 2018120305264948300_eux376-B4) 2017 Ullah ( key 2018120305264948300_eux376-B13) 2016; 13 Afzal ( key 2018120305264948300_eux376-B12) 2015; 12 Calkins ( key 2018120305264948300_eux376-B1) 2012; 14 Reddy ( key 2018120305264948300_eux376-B14) 2015; 132 Kuck ( key 2018120305264948300_eux376-B7) 2016; 374 Andrade ( key 2018120305264948300_eux376-B9) 2014; 11 El Haddad ( key 2018120305264948300_eux376-B3) 2017; 10 Black-Maier ( key 2018120305264948300_eux376-B20) 2017; 14 Kirchhof ( key 2018120305264948300_eux376-B2) 2016; 18 Sarkozy ( key 2018120305264948300_eux376-B6) 2015; 8 Nakagawa ( key 2018120305264948300_eux376-B19) 2013; 10 Halbfass ( key 2018120305264948300_eux376-B21) 2017; 19 Natale ( key 2018120305264948300_eux376-B11) 2014; 64 Itoh ( key 2018120305264948300_eux376-B16) 2016; 18 Reddy ( key 2018120305264948300_eux376-B15) 2016; 2 De Greef ( key 2018120305264948300_eux376-B18) 2010; 21 Wilber ( key 2018120305264948300_eux376-B8) 2010; 303 Marijon ( key 2018120305264948300_eux376-B10) 2014; 25 Tsai ( key 2018120305264948300_eux376-B17) 2000; 102  | 
    
| References_xml | – volume: 303 start-page: 333 year: 2010 ident: key 2018120305264948300_eux376-B8 article-title: Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.2009.2029 – volume: 18 start-page: 531 year: 2016 ident: key 2018120305264948300_eux376-B16 article-title: Reduced residual conduction gaps and favourable outcome in contact force-guided circumferential pulmonary vein isolation publication-title: Europace doi: 10.1093/europace/euv206 – volume: 64 start-page: 647 year: 2014 ident: key 2018120305264948300_eux376-B11 article-title: Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.04.072 – volume: 14 start-page: 528 year: 2012 ident: key 2018120305264948300_eux376-B1 article-title: 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design publication-title: Europace doi: 10.1093/europace/eus027 – volume: 21 start-page: 381 year: 2010 ident: key 2018120305264948300_eux376-B18 article-title: Triggering pulmonary veins: a paradoxical predictor for atrial fibrillation recurrence after PV isolation publication-title: J Cardiovasc Electrophysiol doi: 10.1111/j.1540-8167.2009.01646.x – volume: 18 start-page: 1609 year: 2016 ident: key 2018120305264948300_eux376-B2 article-title: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS publication-title: Europace doi: 10.1093/europace/euw295 – volume: 10 start-page: S481 year: 2013 ident: key 2018120305264948300_eux376-B19 article-title: Prospective study to test the ability to create RF lesions at predicted depths of 3, 5, 7 and 9 mm using a new formula incorporating contact force, radiofrequency power and application time (force-power-time index) in the beating canine heart publication-title: Heart Rhythm – volume: 19 start-page: 1116 year: 2017 ident: key 2018120305264948300_eux376-B21 article-title: Impact of surround flow catheter tip irrigation in contact force ablation on the incidence of asymptomatic oesophageal lesions after atrial fibrillation ablation: a prospective comparative study publication-title: Europace – volume: 21 start-page: 1038 year: 2010 ident: key 2018120305264948300_eux376-B5 article-title: Area under the real-time contact force curve (force-time integral) predicts radiofrequency lesion size in an in vitro contractile model publication-title: J Cardiovasc Electrophysiol doi: 10.1111/j.1540-8167.2010.01750.x – volume: 2 start-page: 691 year: 2016 ident: key 2018120305264948300_eux376-B15 article-title: Relationship between catheter stability and 12-month success after pulmonary vein isolation: a subanalysis of the SMART-AF trial publication-title: J Am Coll Cardiol – volume: 374 start-page: 2235 year: 2016 ident: key 2018120305264948300_eux376-B7 article-title: Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1602014 – volume: 25 start-page: 130 year: 2014 ident: key 2018120305264948300_eux376-B10 article-title: Real-time contact force sensing for pulmonary vein isolation in the setting of paroxysmal atrial fibrillation: procedural and 1-year results publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.12303 – volume: 102 start-page: 67 year: 2000 ident: key 2018120305264948300_eux376-B17 article-title: Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation publication-title: Circulation doi: 10.1161/01.CIR.102.1.67 – volume: 11 start-page: 1919 year: 2014 ident: key 2018120305264948300_eux376-B9 article-title: Pulmonary vein isolation using contact force ablation: the effect on dormant conduction and long-term freedom from recurrent atrial fibrillation. A prospective study publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2014.07.033 – volume: 13 start-page: 1761 year: 2016 ident: key 2018120305264948300_eux376-B13 article-title: Randomized trial comparing pulmonary vein isolation using the SmartTouch catheter with or without real-time contact force data publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2016.05.011 – volume: 8 start-page: 1342 year: 2015 ident: key 2018120305264948300_eux376-B6 article-title: Contact force in atrial fibrillation: role of atrial rhythm and ventricular contractions: co-force atrial fibrillation study publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.115.003041 – volume: 10 start-page: e004867. year: 2017 ident: key 2018120305264948300_eux376-B3 article-title: Determinants of acute and late pulmonary vein reconnection in contact force guided pulmonary vein isolation publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.116.004867 – year: 2017 ident: key 2018120305264948300_eux376-B4 article-title: Evaluation of a strategy aiming to enclose the pulmonary veins with contiguous and optimized radiofrequency lesions in paroxysmal atrial fibrillation: a pilot study publication-title: JACC Clinical Electrohysiol – volume: 14 start-page: 1328 year: 2017 ident: key 2018120305264948300_eux376-B20 article-title: Risk of atrioesophageal fistula formation with contact force-sensing catheters publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2017.04.024 – volume: 12 start-page: 1990 year: 2015 ident: key 2018120305264948300_eux376-B12 article-title: Use of contact force sensing technology during radiofrequency ablation reduces recurrence of atrial fibrillation: a systematic review and meta-analysis publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2015.06.026 – volume: 132 start-page: 907 year: 2015 ident: key 2018120305264948300_eux376-B14 article-title: Randomized controlled trial of the safety and effectiveness of a contact-force sensing irrigated catheter for ablation of paroxysmal atrial fibrillation (Toccastar study) publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.014092  | 
    
| SSID | ssj0007295 | 
    
| Score | 2.6336198 | 
    
| Snippet | We have recently shown that a contact force (CF)-guided ablation protocol respecting region-specific criteria of lesion contiguity and lesion depth ('CLOSE'... | 
    
| SourceID | unpaywall proquest pubmed crossref  | 
    
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source  | 
    
| StartPage | f419 | 
    
| Title | Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol | 
    
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29315411 https://www.proquest.com/docview/1989554299 https://academic.oup.com/europace/article-pdf/20/FI_3/f419/26947528/eux376.pdf  | 
    
| UnpaywallVersion | publishedVersion | 
    
| Volume | 20 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1532-2092 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007295 issn: 1099-5129 databaseCode: KQ8 dateStart: 19990101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1532-2092 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0007295 issn: 1099-5129 databaseCode: DIK dateStart: 19990101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1532-2092 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0007295 issn: 1099-5129 databaseCode: GX1 dateStart: 19990101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1532-2092 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007295 issn: 1099-5129 databaseCode: RPM dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVASL databaseName: Oxford Journals Open Access Collection customDbUrl: eissn: 1532-2092 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007295 issn: 1099-5129 databaseCode: TOX dateStart: 19990101 isFulltext: true titleUrlDefault: https://academic.oup.com/journals/ providerName: Oxford University Press  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwEB61W4mfA78Flp_KSBxAqneT2M5uequqrgqiWyS60nKKbMdGK1bJqiSF5dTHgFfiMfokHcfJQkEIIXGMMrYTe8bzJTP-BuCZ4cpGuAniCoSCcs1cNUA9pFzFSloltKwj-Ifj-GDCX03FdA3G7VkY2WSF99ojDY6iAr8eTb-ZSbrILH6x90cvU9a3PEz67izmQERDFP2M5tJDgXXYiAVi8w5sTMZvdt_VIc8koc67eQLVCB8uiVqun4T9GMf3ctlN_YY9r8PVKl_I5Sc5n__kj0Y3oWjfxKehfOhVperpL7-QPP6_V70FNxroSnZ9s9uwZvI7cOWwCc7fhe-rHxSkdouZY_QgMs9IkRu6RJMiRVXiIxhSVyYnLk1e6pIgbtaGvq9mmcnIopqjZciTJTk1s5zM0DZq5dkhCFWJS4YkhSWO5cKlCeANkjkIjLq7TaTysqTmgNyux740CDmVaHB1PvASheouz8--7r0-ert_fvaNOtaKAk1jEyaj_eO9A9qUiqCaB7ykQuNmlEib8dgEgRbcMh0NlOYssHiNfpoPLWqljXRojQmEYFk4CBSLVRijorB70MlxMh4AcXNsFPp2aS32xmUkecY0i3RiOOKpLvRazUh1w6PuynnMUx_PZ2m7jqlfpS48XzVYeAqRP4s-bVUtRTN3sRuZm6L6mLrUNuFqiyVduO91cNUZIjYEwmHYhRcrpfzbSA__QfYRXENLHvoTmI-hU55U5glCsVJtwfrx0XSrsbIL3kk9YQ | 
    
| linkProvider | Unpaywall | 
    
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3bbtQwEB2VrcTlgWuB5aZB4gGkejeJ7eyGt6rqqiC6IMFK5SmyHRutWCWrkhSWp34G_BKf0S9hnMtCQQgh8RhlbCf2jOckMz4D8MgK7SLaBGkFQsmE4b4aoBkzoWOtnJZG1RH8g2m8PxPPD-XhBky7szCqzQofdEcaPEUFfT3aYTuTbJk5-mIfTp6lfOhEmAz9WcyRjMYk-onMZUAC52AzloTNe7A5m77aeVuHPJOEee_WEKhG9HBJ1HH9JPzHOE0vZ93Ub9jzElyo8qVafVSLxU_-aHIFiu5NmjSU94Oq1APz-ReSx__3qlfhcgtdcadpdg02bH4dzh-0wfkb8G39gwJrt5h5Rg9UeYZFbtmKTAqLqqRHsFhXJkefJq9MiYSbjWXvqnlmM1xWC7IMdbTCYzvPcU62USvPUySoij4ZEguHnuXCpwnQDcw8BCbd3UalG1msOSC367HPDILHigyuzgdekVDd5enJl90XL1_vnZ58ZZ61oiDT2ILZZO_N7j5rS0UwIwJRMmloM0qUy0Rsg8BI4biJRtoIHji6Jj8txo600kUmdNYGUvIsHAWaxzqMSVH4TejlNBm3Af0cW02-XTlHvQkVKZFxwyOTWEF4qg-DTjNS0_Ko-3Iei7SJ5_O0W8e0WaU-PF43WDYUIn8WfdipWkpm7mM3KrdF9SH1qW3S1xZL-nCr0cF1Z4TYCAiHYR-erJXybyPd-QfZu3CRLHncnMC8B73yqLL3CYqV-kFrX98Bcyo8RQ | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improving+procedural+and+one-year+outcome+after+contact+force-guided+pulmonary+vein+isolation%3A+the+role+of+interlesion+distance%2C+ablation+index%2C+and+contact+force+variability+in+the+%27CLOSE%27-protocol&rft.jtitle=Europace+%28London%2C+England%29&rft.au=Phlips%2C+Thomas&rft.au=Taghji%2C+Philippe&rft.au=El+Haddad%2C+Milad&rft.au=Wolf%2C+Michael&rft.date=2018-11-01&rft.eissn=1532-2092&rft.volume=20&rft.issue=FI_3&rft.spage=f419&rft_id=info:doi/10.1093%2Feuropace%2Feux376&rft_id=info%3Apmid%2F29315411&rft.externalDocID=29315411 | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1099-5129&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1099-5129&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1099-5129&client=summon |